Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jan 1;92(1):133-136.
doi: 10.1097/SAP.0000000000003711. Epub 2023 Oct 23.

Abdominoplasty in a Patient With Type 3 von Willebrand Disease: A Case Report

Affiliations
Case Reports

Abdominoplasty in a Patient With Type 3 von Willebrand Disease: A Case Report

Sinan Mert et al. Ann Plast Surg. .

Abstract

von Willebrand disease (vWD) is an inherited bleeding disorder that is characterized by a quantitative or qualitative deficiency of the von Willebrand factor (vWF). Type 3 is the most severe form of vWD with a near-complete absence of vWF and a significantly increased risk of excessive bleeding and hematoma during a surgical procedure. To date, no data on surgical and hemostatic management of a type 3 vWD patient undergoing body-contouring surgery has been published. We report the case of a 47-year-old woman with type 3 vWD requiring medically indicated abdominoplasty after massive weight loss due to bariatric surgery. The case was successfully managed with individualized bodyweight-adapted substitution of recombinant vWF vonicog alfa and tranexamic acid under close monitoring of vWF and factor VIII activity. For further risk stratification, we propose the multidisciplinary treatment of patients with severe vWF undergoing elective plastic surgery in specialized centers providing around-the-clock laboratory testing and access to a blood bank. In addition, strict hemostasis during surgery and early postoperative mobilization with fitted compression garments are recommended to further reduce the risk of bleeding and thromboembolic complications.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: none declared.

Similar articles

Cited by

References

    1. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med . 2004;351:683–694.
    1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood . 1987;69:454–459.
    1. Pietu G, Fressinaud E, Girma JP, et al. Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets. J Lab Clin Med . 1987;109:637–646.
    1. Miesbach W. Perioperative management for patients with von Willebrand disease: defining the optimal approach. Eur J Haematol . 2020;105:365–377.
    1. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia . 2008;14:171–232.

Publication types

LinkOut - more resources